Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1Other hematologic neoplasm 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 2Waldenstrom Macroglobulinemia 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 49fludarabine phosphate 37Peripheral Blood Stem Cell Transplantation 32Cyclosporine 30Mycophenolic Acid 29Busulfan 27Whole-Body Irradiation 25Radiotherapy 24Antilymphocyte Serum 24Filgrastim 23Melphalan 18Tacrolimus 16Methylprednisolone 15Cord Blood Stem Cell Transplantation 15Methotrexate 14Etoposide 12Thiotepa 8sargramostim 6Cytarabine 6Rituximab 5fludarabine 4aldesleukin 4Therapeutics 4Sirolimus 4Carmustine 4Biopsy 4thymoglobulin 3Polymerase Chain Reaction 3Paclitaxel 3Itraconazole 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × pirtobrutinib × Sarcoma × Clear all
NCT03740529 2026-01-27

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Eli Lilly and Company

Phase 1/2 Completed
803 enrolled 2 FDA
LymphoidOther hematologic neoplasmSarcoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡